152,445 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Lisanti Capital Growth LLC

Key Points

• Lisanti Capital Growth LLC initiated a position in Acadia Healthcare by purchasing 152,445 shares valued at approximately $4.5 million, representing about 0.16% of the company.
• Acadia reported quarterly EPS of $0.38, exceeding the $0.35 analyst consensus, while revenue of $865.84 million also topped estimates. However, revenue declined 0.4% year over year and the company posted a negative net margin.
• Analyst sentiment is mixed: price targets were raised by Guggenheim, Raymond James and KeyCorp, but the overall consensus rating remains “Hold” with an average price target of $29.85.

Lisanti Capital Growth LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 152,445 shares of the company's stock, valued at approximately $4,502,000. Lisanti Capital Growth LLC owned about 0.16% of Acadia Healthcare at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its stake in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN grew its holdings in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock valued at $32,000 after buying an additional 1,510 shares during the last quarter. Bayforest Capital Ltd bought a new position in Acadia Healthcare in the 4th quarter worth approximately $52,000. Global Retirement Partners LLC bought a new position in Acadia Healthcare in the 2nd quarter worth approximately $68,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company's stock worth $76,000 after buying an additional 5,203 shares during the last quarter.

Acadia Healthcare Stock Down 0.4%

ACHC opened at $27.36 on Thursday. The company has a market capitalization of $2.55 billion, a P/E ratio of -2.20, a P/E/G ratio of 8.89 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The firm's fifty day moving average price is $29.86 and its two-hundred day moving average price is $25.39. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million during the quarter, compared to analysts' expectations of $844.19 million. During the same quarter in the prior year, the company posted $0.83 EPS. The business's revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Guggenheim raised their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 30th. Weiss Ratings reissued a "sell (d)" rating on shares of Acadia Healthcare in a report on Friday, June 12th. Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 price target on the stock in a research report on Monday, May 4th. Cantor Fitzgerald restated a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Finally, KeyCorp upped their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source